Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F3PC
|
|||
Former ID |
DNC002230
|
|||
Drug Name |
ISIS 111121
|
|||
Drug Type |
Antisense drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Company |
Isis Pharmaceuticals
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cytohesin-2 messenger RNA (CYTH2 mRNA) | Target Info | . | [1] |
KEGG Pathway | Endocytosis | |||
Pathway Interaction Database | Arf6 signaling events | |||
Class I PI3K signaling events | ||||
Arf1 pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | US patent application no. 6,271,029, Antisense inhibition of cytohesin-2 expression. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.